<p>A) Well differentiated primary HBE cells were treated with 50 ng/ml IFN γ and/or 25 µg/ml dsRNA for 24 hours in the presence or absence of IκB kinase or JAK inhibitor. RNA was isolated followed by qPCR. Solvent Control: black bar; IκB kinase inhibitor: grey bar; JAK inhibitor: light grey bar. $: p<0.05. Inhibitor treatment vs. solvent control. B) Cells were treated with 50 ng/ml IFN γ and/or 25 µg/ml dsRNA for 3 hours. Cellular protein was collected and analyzed by western blot analysis. Actin was used as a loading control. pSTAT1: phosphorylated STAT1. This is the representative image from three replicates.</p
<p>A to C shows FCM analysis of HCE-T cells treated with BMS-345541 (5 µM), a NF-κB pathway inhibito...
<p>BEAS-2B cells were pre-treated for 1h with either PF956980 or PF1367550 followed by stimulation f...
<p>Control (white bars), Mda5-knockdown (striped bars) and TLR3-knockdown (black bars) DF-1 cells we...
<p>Well differentiated primary HBE cells were treated with 50/ml IFN γ and/or 25 µg/ml dsRNA. RNA wa...
<p><b>(A)</b> S3-GFP and R4-GFP cells treated with either IFN-α or IFN-λ for 30 minutes. Cell lysate...
<p>A) HBE cells were treated with 2.5 µg/ml of either an isotype control antibody (black bar) or a m...
<p><b>(A)</b> R4-GFP and S3-GFP cells treated with IFN-α (1000 I.U/ml) or IFN-λ (100 ng/ml) for 5, 1...
<p>(A) HeLa cells were transfected with siRNA targeting IKKα or control siRNA for 48 h. Then, the ce...
<p>BEAS-2B cells were pre-treated with either PF956980 (PF956) or PF1367550 (PF136) for 1h followed ...
<p>(A)<b>NSs of SFTSV expresses in Hela cells successfully.</b> Hela cells were transfected with emp...
<p>(A) Effect of down-regulation of DDRGK1 on the NF-κB family protein expression. U2OS cells were t...
Cells must adapt to changes in their environment to maintain cell, tissue and organismal integrity i...
<p><b>A.</b> The cells were treated with 50 U/ml, 100 U/ml, or 150 U/ml IFN-γ for 24 hrs. MTT assay ...
<p>The cytoplasmic and nuclear content of the NFκB pathway enhancer Ribosomal Protein S3 (RPS3) (<b>...
(A) Confocal projections of cells stained for STAT3 and DAPI. Bars, 20 μm. (B) Quantitation of STAT3...
<p>A to C shows FCM analysis of HCE-T cells treated with BMS-345541 (5 µM), a NF-κB pathway inhibito...
<p>BEAS-2B cells were pre-treated for 1h with either PF956980 or PF1367550 followed by stimulation f...
<p>Control (white bars), Mda5-knockdown (striped bars) and TLR3-knockdown (black bars) DF-1 cells we...
<p>Well differentiated primary HBE cells were treated with 50/ml IFN γ and/or 25 µg/ml dsRNA. RNA wa...
<p><b>(A)</b> S3-GFP and R4-GFP cells treated with either IFN-α or IFN-λ for 30 minutes. Cell lysate...
<p>A) HBE cells were treated with 2.5 µg/ml of either an isotype control antibody (black bar) or a m...
<p><b>(A)</b> R4-GFP and S3-GFP cells treated with IFN-α (1000 I.U/ml) or IFN-λ (100 ng/ml) for 5, 1...
<p>(A) HeLa cells were transfected with siRNA targeting IKKα or control siRNA for 48 h. Then, the ce...
<p>BEAS-2B cells were pre-treated with either PF956980 (PF956) or PF1367550 (PF136) for 1h followed ...
<p>(A)<b>NSs of SFTSV expresses in Hela cells successfully.</b> Hela cells were transfected with emp...
<p>(A) Effect of down-regulation of DDRGK1 on the NF-κB family protein expression. U2OS cells were t...
Cells must adapt to changes in their environment to maintain cell, tissue and organismal integrity i...
<p><b>A.</b> The cells were treated with 50 U/ml, 100 U/ml, or 150 U/ml IFN-γ for 24 hrs. MTT assay ...
<p>The cytoplasmic and nuclear content of the NFκB pathway enhancer Ribosomal Protein S3 (RPS3) (<b>...
(A) Confocal projections of cells stained for STAT3 and DAPI. Bars, 20 μm. (B) Quantitation of STAT3...
<p>A to C shows FCM analysis of HCE-T cells treated with BMS-345541 (5 µM), a NF-κB pathway inhibito...
<p>BEAS-2B cells were pre-treated for 1h with either PF956980 or PF1367550 followed by stimulation f...
<p>Control (white bars), Mda5-knockdown (striped bars) and TLR3-knockdown (black bars) DF-1 cells we...